Pharmafile Logo
Pharmafocus logo
Advanced Search

First UK patient treated with CSL Behring’s gene therapy for Haemophilia B

June 20, 2025
Research and Development CSL Behring, Haematology, NHS England, cell therapy, gene therapy, haemophilia B, prophylactic infusions

CSL Behring has announced that the first patient in the UK has received HEMGENIX (etranacogene dezaparvovec) through the NHS, marking …

News

Eyestem completes phase 1 trial of retinal cell therapy with promising vision gains

June 20, 2025
Research and Development Eyestem Research, Opthalmology, cell therapy, clinical trial, dry age-related macular degeneration, geographic atrophy

Eyestem Research has announced the successful completion of its phase 1 trial evaluating Eyecyte-RPE, an investigational cell therapy for geographic …

News
money-2180330_960_720

Nanoform receives €5m loan from Finnish government to accelerate its nanotechnology

June 20, 2025
Freelancers, Licensing & business development, Research and Development Devices, Johnson & Johnson, Nanoform Finland, Oncology, amorphous solid dispersion technology, government loan, nanoparticle medicine, nanotechnology, prostate cancer

Nanoform Finland [Nanoform], a leading nanoparticle medicine company, is pleased to announce that Business Finland has approved a €5m research …

News

Celltrion opens new UK headquarters in Uxbridge to drive long-term growth

June 19, 2025
Research and Development Corporate, Pharmacy, biosimilar medicines, celltrion

Celltrion, focused on the development of biosimilar medicines, has officially opened its new UK headquarters in the Charter Building, Uxbridge, …

News
handshake

KFSHRC and Germfree to launch first modular ATMP manufacturing campus in Saudi Arabia

June 19, 2025
Medical Communications, Research and Development Advanced Therapy Medicinal Product manufacturing, BIO 2025, Corporate, King Faisal Specialist Hospital & Research Centre, Saudi Arabia, biotechnology development, cell therapies, gene therapies

King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a landmark partnership with Germfree Laboratories to develop Saudi Arabia’s …

News

Alan Perkins awarded MBE for services to patient care and clinical science

June 19, 2025
Medical Communications Devices, MBE, Serac Life Sciences, medical imaging technology, molecular imaging, nuclear medicine, scientific advisor

Serac Life Sciences has announced that Alan Perkins, scientific advisor to its subsidiaries Serac Healthcare and Serac Imaging Systems, has …

News
AstraZeneca_drug_discovery

Bristol Myers Squibb to present positive new data on lymphoma treatment

June 18, 2025
Medical Communications, Research and Development Bristol Myers Squibbs, CAR T-cell therapy, International Conference on Malignant Lymphoma, Oncology, relapsed or refractory marginal zone lymphoma

Bristol Myers Squibb (BMS) has announced positive results from the TRANSCEND FL phase 2 study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) …

News
lab

Captain T Cell joins Bayer Co.Lab Berlin to accelerate TCR therapies

June 18, 2025
Analytical & Laboratory Services, Business Services, Research and Development Bayer Co.Lab, Bayer Co.Lab Berlin, Captain T Cell, Corporate, T-cell receptor therapy, laboratory services

Captain T Cell, a biotech company developing next-generation T-cell receptor (TCR)-based therapies for solid tumours, has announced its selection for …

News
money_pills_2

EVerZom receives €3m funding from French government to industrialise exosome technology

June 18, 2025
Research and Development BpiFfrance, Corporate, Crohn’s disease, EVerZom, France 2030, French government, age-related disorders, exosome therapy, neurodegenerative disease

EVerZom, a French biopharma company focused on exosome-based therapies, has announced it has received €3m in funding as part of …

News

Samra Turajlić appointed director of Cancer Research UK Manchester Institute

June 18, 2025
Medical Communications, Research and Development Cancer Research UK, Cancer Research UK Manchester Institute, Oncology, The Royal Marsden NHS Foundation Trust, University of Manchester, cancer research

Cancer Research UK has announced the appointment of Samra Turajlić as the new director of the Cancer Research UK Manchester …

Appointment
woman-smartphone-girl-technology

Smartphone app for treating depression launches in UK

June 17, 2025
Clinical & Scientific, Freelancers NHS trusts, Psychiatry, Rejoyn, digital therapeutics, major depressive disorder, mental health

Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The …

News

Astoriom appoints Brittany Jackson as CFO

June 17, 2025
Business Services Astoriom, Corporate, R&D sample stability and biorepository storage, cfo

Astoriom, a R&D sample stability and biorepository storage company, has appointed Brittany Jackson as chief financial officer (CFO). Jackson will …

Appointment

Biotium launches new DNA gel analysis technology

June 17, 2025
Business Services, Research and Development Biotium, Corporate, DNA gel analysis, DNAzure blue nucleic acid gel stain, glo-plate white photoactivation device, life sciences reagents

Biotium has announced the launch of its new glo-plate white photoactivation device, a compact LED-powered light box designed to support …

News
Bowel cancer screening image

Scientists discover reason for resistance to bowel cancer treatment

June 17, 2025
Research and Development Cancer Research UK, Oncology, The Institute of Cancer Research, bowel cancer, drug resistance

Scientists funded by Cancer Research UK have demonstrated what may cause some treatments to stop working in people living with …

News

Johnson & Johnson presents promising data on leukaemia treatment

June 16, 2025
Medical Communications, Research and Development European Hematology Association, Janssen-Cilag, Johnson & Johnson, Oncology, chronic lymphocytic leukaemia, clinical trial

Janssen-Cilag, a Johnson & Johnson company, has announced results from a matching-adjusted indirect comparison presented at this year’s European Hematology …

News

GCI Health appoints Aneeb Sharif as EMEA head of policy

June 16, 2025
Business Services, Medical Communications, Public Relations Corporate, EMEA Head of Policy, GCI Health, healthcare communications agency, healthcare policy analysis, patient advocacy, public affairs

Healthcare communications agency, GCI Health, has announced the appointment of Aneeb Sharif as Europe, Middle East and Africa (EMEA) head …

Appointment

Roche advances treatment for Parkinson’s disease

June 16, 2025
Research and Development Neurology, Parkinson's disease, Roche, clinical trials, neurodegenerative disease

Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s …

News
handshake

Shilpa Medicare and Orion partner, expanding into European market

June 16, 2025
Manufacturing and Production Corporate, Orion Corporation, Shilpa Biocare, Shilpa Medicare, commercial supply agreement, plasma protein, recombinant human albumin

Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for …

News
lab

Bristol Myers Squibb reports positive results for psoriatic arthritis treatment

June 13, 2025
Medical Communications, Research and Development European Alliance of Associations for Rheumatology, Rheumatology, bristol myers squibb, clinical trial, psoriatic arthritis

Bristol Myers Squibb (BMS) has presented new data from its phase 3 POETYK PsA-1 trial, showing that Sotyktu (deucravacitinib) significantly …

News

EpiEndo publishes new data supporting glasmacinal’s potential in COPD

June 13, 2025
Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease

EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025